BioMall
Brand Store/BDB Bioscience/BD PharmingenTM PE Mouse Anti-Human FCRL5 (CD307e)
BD PharmingenTM PE Mouse Anti-Human FCRL5 (CD307e)
GENERAL CATALOGUE

BD PharmingenTM PE Mouse Anti-Human FCRL5 (CD307e)

566734 ·

BDB Bioscience · Cat: 566734

₹240 – ₹370 approx.This price excludes freight and taxes. Please RFQ to get the final price.

Reach 3+ verified distributors

Catalog No: 566734
Category: reagents
Brand: BDB Bioscience

Description

Flow cytometric analysis of FCRL5 CD307e expression on transfectants and tonsillar B cells. Left Plot: Non-transfected Dotted line histogram and Human FCRL5-transfected Solid line histogram P815 cells were surface stained with PE Mouse Anti-Human FCRL5 CD307e Cat. No. 566734 at 0.5 mug/test. Flow cytometric fluorescence histograms showing the expression of FCRL5 CD307e on non-transfected or Human FCRL5-transfected P815 cells were derived from gated events with the forward and side light-scatter characteristics of viable cells. Flow cytometry and data analysis were performed using a BD LSRFortessa Cell Analyzer System and FlowJo software. Middle and Right Plots: Tonsil cells were treated with an Fc receptor blocker and stained with APC Mouse Anti-Human CD19 Cat. No. 561742 or 555415 and either PE Mouse Anti-Human FCRL5 CD307e Cat. No. 566734; Middle Plot or PE Mouse IgG2a, kappa Isotype Control Cat. No. 554648; Right Plot . Two-color flow cytometric dot plots show the correlated expression patterns of FCRL5 CD307e or Ig isotype control staining versus Human CD19 for gated events with the forward and side light-scatter characteristics of viable lymphocytes. Flow cytometry and data analysis were performed using a BD FACSCalibur Flow Cytometer System and FlowJo software. Data courtesy of Dr. Marco Colonna, Washington University School of Medicine. Data shown on this Technical Data Sheet are not lot specific. Flow cytometric analysis of FCRL5 CD307e expression on transfectants and tonsillar B cells. Left Plot: Non-transfected Dotted line histogram and Human FCRL5-transfected Solid line histogram P815 cells were surface stained with PE Mouse Anti-Human FCRL5 CD307e Cat. No. 566734 at 0.5 mug/test. Flow cytometric fluorescence histograms showing the expression of FCRL5 CD307e on non-transfected or Human FCRL5-transfected P815 cells were derived from gated events with the forward and side light-scatter characteristics of viable cells. Flow cytometry and data analysis were performed using a BD LSRFortessa Cell Analyzer System and FlowJo software. Middle and Right Plots: Tonsil cells were treated with an Fc receptor blocker and stained with APC Mouse Anti-Human CD19 Cat. No. 561742 or 555415 and either PE Mouse Anti-Human FCRL5 CD307e Cat. No. 566734; Middle Plot or PE Mouse IgG2a, kappa Isotype Control Cat. No. 554648; Right Plot . Two-color flow cytometric dot plots show the correlated expression patterns of FCRL5 CD307e or Ig isotype control staining versus Human CD19 for gated events with the forward and side light-scatter characteristics of viable lymphocytes. Flow cytometry and data analysis were performed using a BD FACSCalibur Flow Cytometer System and FlowJo software. Data courtesy of Dr. Marco Colonna, Washington University School of Medicine. Data shown on this Technical Data Sheet are not lot specific. Flow cytometric analysis of FCRL5 CD307e expression on transfectants and tonsillar B cells. Left Plot: Non-transfected Dotted line histogram and Human FCRL5-transfected Solid line histogram P815 cells were surface stained with PE Mouse Anti-Human FCRL5 CD307e Cat. No. 566734 at 0.5 mug/test. Flow cytometric fluorescence histograms showing the expression of FCRL5 CD307e on non-transfected or Human FCRL5-transfected P815 cells were derived from gated events with the forward and side light-scatter characteristics of viable cells. Flow cytometry and data analysis were performed using a BD LSRFortessa Cell Analyzer System and FlowJo software. Middle and Right Plots: Tonsil cells were treated with an Fc receptor blocker and stained with APC Mouse Anti-Human CD19 Cat. No. 561742 or 555415 and either PE Mouse Anti-Human FCRL5 CD307e Cat. No. 566734; Middle Plot or PE Mouse IgG2a, kappa Isotype Control Cat. No. 554648; Right Plot . Two-color flow cytometric dot plots show the correlated expression patterns of FCRL5 CD307e or Ig isotype control staining versus Human CD19 for gated events with the forward and side light-scatter characteristics of viable lymphocytes. Flow cytometry and data analysis were performed using a BD FACSCalibur Flow Cytometer System and FlowJo software. Data courtesy of Dr. Marco Colonna, Washington University School of Medicine. Data shown on this Technical Data Sheet are not lot specific. Show More Flow cytometric analysis of FCRL5 CD307e expression on transfectants and tonsillar B cells. Left Plot: Non-transfected Dotted line histogram and Human FCRL5-transfected Solid line histogram P815 cells were surface stained with PE Mouse Anti-Human FCRL5 CD307e Cat. No. 566734 at 0.5 mug/test. Flow cytometric fluorescence histograms showing the expression of FCRL5 CD307e on non-transfected or Human FCRL5-transfected P815 cells were derived from gated events with the forward and side light-scatter characteristics of viable cells. Flow cytometry and data analysis were performed using a BD LSRFortessa Cell Analyzer System and FlowJo software. Middle and Right Plots: Tonsil cells were treated with an Fc receptor blocker and stained with APC Mouse Anti-Human CD19 Cat. No. 561742 or 555415 and either PE Mouse Anti-Human FCRL5 CD307e Cat. No. 566734; Middle Plot or PE Mouse IgG2a, kappa Isotype Control Cat. No. 554648; Right Plot . Two-color flow cytometric dot plots show the correlated expression patterns of FCRL5 CD307e or Ig isotype control staining versus Human CD19 for gated events with the forward and side light-scatter characteristics of viable lymphocytes. Flow cytometry and data analysis were performed using a BD FACSCalibur Flow Cytometer System and FlowJo software. Data courtesy of Dr. Marco Colonna, Washington University School of Medicine. Data shown on this Technical Data Sheet are not lot specific. Show More Flow cytometric analysis of FCRL5 CD307e expression on transfectants and tonsillar B cells. Left Plot: Non-transfected Dotted line histogram and Human FCRL5-transfected Solid line histogram P815 cells were surface stained with PE Mouse Anti-Human FCRL5 CD307e Cat. No. 566734 at 0.5 mug/test. Flow cytometric fluorescence histograms showing the expression of FCRL5 CD307e on non-transfected or Human FCRL5-transfected P815 cells were derived from gated events with the forward and side light-scatter characteristics of viable cells. Flow cytometry and data analysis were performed using a BD LSRFortessa Cell Analyzer System and FlowJo software. Middle and Right Plots: Tonsil cells were treated with an Fc receptor blocker and stained with APC Mouse Anti-Human CD19 Cat. No. 561742 or 555415 and either PE Mouse Anti-Human FCRL5 CD307e Cat. No. 566734; Middle Plot or PE Mouse IgG2a, kappa Isotype Control Cat. No. 554648; Right Plot . Two-color flow cytometric dot plots show the correlated expression patterns of FCRL5 CD307e or Ig isotype control staining versus Human CD19 for gated events with the forward and side light-scatter characteristics of viable lymphocytes. Flow cytometry and data analysis were performed using a BD FACSCalibur Flow Cytometer System and FlowJo software. Data courtesy of Dr. Marco Colonna, Washington University School of Medicine. Data shown on this Technical Data Sheet are not lot specific. Flow cytometric analysis of FCRL5 CD307e expression on transfectants and tonsillar B cells. Left Plot: Non-transfected Dotted line histogram and Human FCRL5-transfected Solid line histogram P815 cells were surface stained with PE Mouse Anti-Human FCRL5 CD307e Cat. No. 566734 at 0.5 mug/test. Flow cytometric fluorescence histograms showing the expression of FCRL5 CD307e on non-transfected or Human FCRL5-transfected P815 cells were derived from gated events with the forward and side light-scatter characteristics of viable cells. Flow cytometry and data analysis were performed using a BD LSRFortessa Cell Analyzer System and FlowJo software. Middle and Right Plots: Tonsil cells were treated with an Fc receptor blocker and stained with APC Mouse Anti-Human CD19 Cat. No. 561742 or 555415 and either PE Mouse Anti-Human FCRL5 CD307e Cat. No. 566734; Middle Plot or PE Mouse IgG2a, kappa Isotype Control Cat. No. 554648; Right Plot . Two-color flow cytometric dot plots show the correlated expression patterns of FCRL5 CD307e or Ig isotype control staining versus Human CD19 for gated events with the forward and side light-scatter characteristics of viable lymphocytes. Flow cytometry and data analysis were performed using a BD FACSCalibur Flow Cytometer System and FlowJo software. Data courtesy of Dr. Marco Colonna, Washington University School of Medicine. Data shown on this Technical Data Sheet are not lot specific.

More from BDB Bioscience

BD HorizonTM BV421 Mouse Anti-Human TIGIT
BD HorizonTM BV421 Mouse Anti-Human TIGIT
570445
reagents
BD OptiBuildTM BV750 Mouse Anti-Human HLA-DQ
BD OptiBuildTM BV750 Mouse Anti-Human HLA-DQ
746968
reagents
BD OptiBuildTM BV750 Rat Anti-Mouse CD93 (Early B Lineage)
BD OptiBuildTM BV750 Rat Anti-Mouse CD93 (Early B Lineage)
746849
reagents
BD OptiBuildTM BV510 Rat Anti-Mouse Delta-Like Protein 1
BD OptiBuildTM BV510 Rat Anti-Mouse Delta-Like Protein 1
744997
reagents
BD OptiBuildTM BUV805 Mouse Anti-Human CD275
BD OptiBuildTM BUV805 Mouse Anti-Human CD275
748933
reagents
BD OptiBuildTM BV650 Rat Anti-Mouse CD23
BD OptiBuildTM BV650 Rat Anti-Mouse CD23
740456
reagents
BD OptiBuildTM R718 Rat Anti-Mouse CCRL2
BD OptiBuildTM R718 Rat Anti-Mouse CCRL2
752021
reagents
BD PharmingenTM Mouse B Lymphocyte Activation Antibody Cocktail, with Isotype Control; PE-CyTM7 CD25, PE CD69, & FITC CD19
BD PharmingenTM Mouse B Lymphocyte Activation Antibody Cocktail, with Isotype Control; PE-CyTM7 CD25, PE CD69, & FITC CD19
558064
reagents